Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?

Por Gebhardt, Brian J., Thomas, Joel, Horne, Zachary D., Champ, Colin E., Farrugia, Daniel J., Diego, Emilia, Ahrendt, Gretchen M., Beriwal, Sushil
Publicado no Adv Radiat Oncol (2018)

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

Por Sakai, Wataru, Swisher, Elizabeth M., Karlan, Beth Y., Agarwal, Mukesh K., Higgins, Jake, Friedman, Cynthia, Villegas, Emily, Jacquemont, Céline, Farrugia, Daniel J., Couch, Fergus J., Urban, Nicole, Taniguchi, Toshiyasu
Publicado em 2008

Functional Assays for Classification of BRCA2 Variants of Uncertain Significance

Por Farrugia, Daniel J., Agarwal, Mukesh K., Pankratz, Vernon S., Deffenbaugh, Amie M., Pruss, Dmitry, Frye, Cynthia, Wadum, Linda, Johnson, Kiley, Mentlick, Jennifer, Tavtigian, Sean V., Goldgar, David E., Couch, Fergus J.
Publicado em 2008

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

Por Lovelock, Paul K, Spurdle, Amanda B, Mok, Myth TS, Farrugia, Daniel J, Lakhani, Sunil R, Healey, Sue, Arnold, Stephen, Buchanan, Daniel, Investigators, kConFab, Couch, Fergus J, Henderson, Beric R, Goldgar, David E, Tavtigian, Sean V, Chenevix-Trench, Georgia, Brown, Melissa A
Publicado em 2007

Detection of Splicing Aberrations Caused by BRCA1 and BRCA2 Sequence Variants Encoding Missense Substitutions: Implications for Prediction of Pathogenicity

Por Walker, Logan C., Whiley, Phillip J., Couch, Fergus J., Farrugia, Daniel J., Healey, Sue, Eccles, Diana M., Lin, Feng, Butler, Samantha A., Goff, Sheila A., Thompson, Bryony A., Lakhani, Sunil R., Da Silva, Leonard M., Tavtigian, Sean V., Goldgar, David E., Brown, Melissa A., Spurdle, Amanda B.
Publicado em 2010